Literature DB >> 15718868

Association between smallpox vaccination and hepatitis C antibody positive serology in Pakistani volunteers.

Muhammad Aslam1, Junaid Aslam, Braxton D Mitchell, Kashif M Munir.   

Abstract

GOALS: To determine whether the smallpox vaccination program has significantly contributed to the widespread prevalence of hepatitis C infection in Pakistan.
BACKGROUND: Hepatitis C virus has become a worldwide pandemic and has especially devastated developing nations such as Pakistan. There continues to be an increase in fatalities due to hepatitis C-related cirrhosis in Pakistan. STUDY: We studied 523 volunteers in the city of Lahore to determine whether the smallpox vaccination program, which ran from 1964 to 1982 in Pakistan, may be responsible for the national surge in hepatitis C viral infection, perhaps because of repetitive use of vaccination devices without proper sterilization or to contaminated vaccine contents.
RESULTS: There was a significantly higher likelihood of hepatitis C antibody seroprevalence in individuals vaccinated for smallpox versus nonvaccinated individuals (21.0% vs. 4.6%, P < 0.001, age-adjusted odds ratio, 3.39; 95% confidence interval, 1.36-8.46). Subjects with positive hepatitis C serology were also more likely to have a history of transfusions (19.2% vs. 9.0%, P = 0.01), but anti-HCV positive serology was not significantly associated with a history of surgery or dental procedures. Following adjustment for age, sex, and history of other conditions, including transfusion, the association between prior smallpox vaccination and hepatitis C antibody seroprevalence remained strong and highly significant (multivariate adjusted odds ratio, 6.11; 95% confidence interval, 2.58-14.51).
CONCLUSION: These results suggest that the widespread prevalence of hepatitis C infection in Pakistan may be an unintended consequence of the country's smallpox vaccination program and that blood transfusion is also a significant risk factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718868     DOI: 10.1097/01.mcg.0000153286.02694.14

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections.

Authors:  Houssein H Ayoub; Laith J Abu-Raddad
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

3.  The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses.

Authors:  Zaina Al Kanaani; Sarwat Mahmud; Silva P Kouyoumjian; Laith J Abu-Raddad
Journal:  R Soc Open Sci       Date:  2018-04-11       Impact factor: 2.963

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.